These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35266822)

  • 1. Antibiotic Treatment of Staphylococcus aureus Infection Inhibits the Development of Protective Immunity.
    Kleinhenz M; Beesetty P; Yang C; Li Z; Montgomery CP
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0227021. PubMed ID: 35266822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A.
    Montgomery CP; Daniels M; Zhao F; Alegre ML; Chong AS; Daum RS
    Infect Immun; 2014 May; 82(5):2125-34. PubMed ID: 24614654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection.
    Zhao F; Cheng BL; Boyle-Vavra S; Alegre ML; Daum RS; Chong AS; Montgomery CP
    Infect Immun; 2015 Sep; 83(9):3712-21. PubMed ID: 26169277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue specificity drives protective immunity against
    Beesetty P; Si Y; Li Z; Yang C; Zhao F; Chong AS; Montgomery CP
    Front Immunol; 2022; 13():795792. PubMed ID: 35983063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
    Adhikari RP; Thompson CD; Aman MJ; Lee JC
    Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
    Mocca CP; Brady RA; Burns DL
    Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection.
    Narita K; Hu DL; Asano K; Nakane A
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection.
    Fritz SA; Tiemann KM; Hogan PG; Epplin EK; Rodriguez M; Al-Zubeidi DN; Bubeck Wardenburg J; Hunstad DA
    Clin Infect Dis; 2013 Jun; 56(11):1554-61. PubMed ID: 23446627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms.
    Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ
    mBio; 2018 Oct; 9(5):. PubMed ID: 30327437
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy.
    Teymournejad O; Li Z; Beesetty P; Yang C; Montgomery CP
    NPJ Vaccines; 2023 Jan; 8(1):3. PubMed ID: 36693884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections.
    Sampedro GR; DeDent AC; Becker RE; Berube BJ; Gebhardt MJ; Cao H; Bubeck Wardenburg J
    J Infect Dis; 2014 Oct; 210(7):1012-8. PubMed ID: 24740631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host factors that contribute to recurrent staphylococcal skin infection.
    Montgomery CP; David MZ; Daum RS
    Curr Opin Infect Dis; 2015 Jun; 28(3):253-8. PubMed ID: 25887613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection.
    Narita K; Asano K; Nakane A
    Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
    Narita K; Hu DL; Asano K; Nakane A
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
    Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
    PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection.
    Li Z; Beesetty P; Gerges G; Kleinhenz M; Moore-Clingenpeel M; Yang C; Ahmed LB; Hensley J; Steele L; Chong AS; Montgomery CP
    J Infect Dis; 2022 Jan; 225(1):177-185. PubMed ID: 34145461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia.
    Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ
    PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
    Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
    PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.